Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>The prostate‐specific phosphatase and tensin homolog deleted on chromosome 10 (<i>Pten)</i> gene‐conditional knockout (KO) mouse carcinogenesis model is highly desirable for studies of prostate cancer biology and chemoprevention due to its close resemblance of primary molecular defect and many histopathological features of human prostate cancer including androgen response and disease progression from prostatic intraepithelial neoplasia to invasive adenocarcinoma. Here, we profiled the proteome and transcriptome of the <i>Pten</i>‐KO mouse prostate tumors for global macromolecular expression alterations for signaling changes and biomarker signatures. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>For proteomics, four pairs of whole prostates from tissue‐specific conditional knockout <i>Pten</i>‐KO mice (12‐15 weeks of age) and their respective wild‐type littermates housed in the same cages were analyzed by 8‐plex isobaric tags for relative and absolute quantitation iTRAQ. For microarray transcriptomic analysis, three additional matched pairs of prostate/tumor specimens from respective mice at 20 to 22 weeks of age were used. Real‐time quantitative reverse transcription‐polymerase chain reaction was used to verify the trends of protein and RNA expression changes. Gene Set Enrichment Analysis and Ingenuity Pathway Analysis were carried out for bioinformatic characterizations of pathways and networks. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>At the macromolecular level, proteomic and transcriptomic analyses complement and cross‐validate to reveal overexpression signatures including inflammation and immune alterations, in particular, neutrophil/myeloid lineage suppressor cell features, chromatin/histones, ion and nutrient transporters, and select glutathione peroxidases and transferases in <i>Pten</i>‐KO prostate tumors. Suppressed expression patterns in the <i>Pten</i>‐KO prostate tumors included glandular differentiation such as secretory proteins and androgen receptor targets, smooth muscle features, and endoplasmic reticulum stress proteins. Bioinformatic analyses identified <i>immune and inflammation responses</i> as the most profound macromolecular landscape changes, and the predicted key nodal activities through Akt, nuclear factor‐kappaB, and P53 in the <i>Pten</i>‐KO prostate tumor. Comparison with other genetically modified mouse prostate carcinogenesis models revealed notable molecular distinctions, especially the dominance of <i>immune and inflammation features</i> in the <i>Pten</i>‐KO prostate tumors. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Our work identified prominent macromolecular signatures and key nodal molecules that help to illuminate the patho‐ and immunobiology of <i>Pten</i>‐loss driven prostate cancer and can facilitate the choice of biomarkers for chemoprevention and interception studies in this clinically relevant mouse prostate cancer model. </p></section>

Quantitative proteomics of TRAMP mice combined with bioinformatics analysis reveals that PDGF-B regulatory network plays a key role in prostate cancer progression.

Figure S1 from Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration

Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods

Transcriptomic analysis of mouse TRAMP cell lines and tumors provide insights into shared pathways and therapeutic targets

Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism

Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer.

Raav-Delivered PTEN Therapeutics for Prostate Cancer

Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining

Adoptive Transfer of Myeloid-Derived Suppressor Cells and T Cells in a Prostate Cancer Model

Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression.

Proteomic and transcriptomic profiling of Pten gene‐knockout mouse model of prostate cancer

Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and Metastasis

Resveratrol Inhibits TRAF6/PTCH/SMO Signal and Regulates Prostate Cancer Progression

Nrf2 Expression is Regulated by Epigenetic Mechanisms in Prostate Cancer of TRAMP Mice.

Loss of epithelial AR increase castration resistant stem-like prostate cancer cells and promotes cancer metastasis via TGF-β1/EMT pathway

Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer

TRAIP suppressed apoptosis and cell cycle to promote prostate cancer proliferation via TRAF2-PI3K-AKT pathway activation

Advances in Prostate Cancer Research Models: from Transgenic Mice to Tumor Xenografting Models

Data from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis

Leveraging cell death patterns to predict metastasis in prostate adenocarcinoma and targeting PTGDS for tumor suppression